Measuring patient activation: the utility of the Patient Activation Measure administered in an interview setting
-
Published:2024-02-22
Issue:5
Volume:33
Page:1389-1400
-
ISSN:0962-9343
-
Container-title:Quality of Life Research
-
language:en
-
Short-container-title:Qual Life Res
Author:
Holter Magdalena, Avian AlexanderORCID, Weger Martin, Strini Sanja, Michelitsch Monja, Brenk-Franz Katja, Wedrich Andreas, Berghold Andrea
Abstract
Abstract
Background
Patient activation is an emerging field in healthcare research concerning knowledge, skills, and confidence of patients in managing their health. This is particularly important for patients with chronic diseases, who often require more complex care management and self-care skills. However, due to temporary or longer-lasting visual impairments, certain patient groups cannot answer a questionnaire independently. The main objective is to investigate the psychometric properties of the German Patient Activation Measure® (PAM) survey in an everyday clinical setting where it has to be read aloud.
Methods
Outpatients with macular edema participated in this questionnaire-based cross-sectional study. The study assessed patient activation by the PAM® survey, self-rated health, self-efficacy, quality of life, and general mood. Interviewers read questionnaires aloud to patients. Psychometric properties of the PAM® survey were investigated by item response theory (IRT), Cronbach’s α and trait–trait correlations.
Results
The analysis included N = 554 patients. Median age was 69 (IQR 62.0–76.0) years and mean overall activation score 74.1 (SD 13.7). All items showed ceiling effects. Empirical reliability from the IRT model and Cronbach’s α were 0.75. The PAM® survey showed a Spearman correlation of 0.54 with self-efficacy, 0.51 with quality of life and 0.34 with general mood.
Conclusion
The read-aloud PAM® survey has been shown to provide to adequate measurement precision and convergent validity to be used as a screening tool in an everyday clinical setting. Objective assessment in an interview setting with the PAM® survey is possible. PAM® items are good in distinguishing lower to middle activated patients, but not patients with high activation. Further, issues with structural validity need more investigation.
Funder
Medical University of Graz
Publisher
Springer Science and Business Media LLC
Reference56 articles.
1. World Health Organization. (2022). World health statistics 2022: Monitoring health for the SDGs, sustainable development goals. World Health Organization. 2. Hibbard, J. H., Stockard, J., Mahoney, E. R., & Tusler, M. (2004). Development of the Patient Activation Measure (PAM): Conceptualizing and measuring activation in patients and consumers. Health Services Research, 39, 1005–1026. 3. Mosen, D. M., Schmittdiel, J., Hibbard, J., Sobel, D., Remmers, C., & Bellows, J. (2007). Is patient activation associated with outcomes of care for adults with chronic conditions? Journal of Ambulatory Care Management, 30, 21–29. 4. Dixon, A., Hibbard, J., & Tusler, M. (2009). How do people with different levels of activation self-manage their chronic conditions? The Patient: Patient-Centered Outcomes Research, 2, 257–268. 5. Brenk-Franz, K., Hibbard, J. H., Herrmann, W. J., Freund, T., Szecsenyi, J., Djalali, S., Steurer-Stey, C., Sönnichsen, A., Tiesler, F., Storch, M., Schneider, N., Gensichen, J. (2013). Validation of the German version of the Patient Activation Measure 13 (PAM13-D) in an international multicentre study of primary care patients. PLoS ONE, 8, e74786.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|